Anonymous. 2008. American Heart Association.
Coronary Risk Profile. Available. 2008.
from: http://www.americanheart.org/presenter.jhtml
?identifier=4528.
Arslan, R., Bor, Z., Bektas, N., Meriçli, A.H., Ozturk,
Y. 2010. Antithrombotic Effects of Ethanol Extract
of Crataegus orientalis in the Carrageenan-Induced
Mice Tail Thrombosis Model. Thrombosis Research,
127 (3):210-3.
Barnes, J., Anderson, L.A., Phillipson, J.D. 1996.
Herbal Medicines: A Guide for Health-Care
Professionals Herbal Medicines. 2nd ed.
Pharmaceutical Press Publication, London, p.284-
287.
Blumenthal, M. 2001. Market Report. Herbalgram 51:
69.
Brevoort, P. 1998. The Booming US Botanical Market.
Herbalgram; 44: 33–48.
Ernst, E, Pittler, M.H., Stevinson, C., White, A.R. 2001.
The Desktop Guide Tocomplementary and
Alternative Medicine: An Evidence Based
Approach. Edinburgh, UK: Mosby.
Felker, G.M., O′Connor, CM. 2001. Inotropic Therapy
for Heart Failure: An Evidence Based Approach.
American Heart Journal, 42: 393-401.
Froehlichera, T., Hennebelleb, T., Nizardc, F.M.,
Cleenewerck, P., Hilberta, J.L., Trotina, F., Grec, S.
2009. Phenolic Profiles and Antioxidative Effects of
Hawthorn Cell Suspensions, Fresh Fruits and
Medicinal Dried Parts. Food Chemistry, 115 (3):
897–903.
Guo, C. 2003. Antioxidant Activities of Peel, Pulp and
Seed Fractions of Common Fruits As Determined by
FRAP Assay. Nutrition Researches, 23: 1719-1726.
Hoffman, D.L. 2006. Hawthorn (online).
Availablefrom:URL:http://www.crystalgardenherbs.
com/HerbRefH.htm.
Hanack, T., Bruckel, M.H. 1983. The Treatment of Mild
Stable Forms of Angina Pectoris Using Crategutt
novo. Therapiewoche, 33:4331-4333.
Holzl, J. 1988. Studies of Pharmacological Mechanism
of Crataegus Fraction and Their Analytical
Characteristics. Archiv Der Pharmazie, 321, 631.
Hosseinimehr, S.J., Mahmoudzadeh, A., Azadbakht, M.
Akhlaghpoor, S. 2009. Radioprotective Effects of
Hawthorn Against Genotoxicity Induced by Gamma
Irradiation in Human Blood Lymphocytes. Radiation
and Environmental Biophysics, 48(1): 95-98.
Kingston, R. A. 2007. Phyotchemical Analysis of
Selected Constituents of Crataegus Flos and Fruct.
to Determine Whether Ethanol, Whiskey and Brandy
Solvents Affect the Chemical Constituent Profile of
the Herbal Preparations. Scottish School of Herbal
Medicine.
Kris-Etherton, PM., Hecker, KD., Bonanome, A.,
Coval, SM., Binkoski, AE., Hilpert, K. F. 2002.
Bioactive Compounds in Foods: Their Role in the
Prevention of Cardiovascular Disease and Cancer.
American Journal of Medicine, 113: 71-88.
Null, G. 2005. Complete Encyclopedia of Natural
Healing. New York: Kensington Books.
Rietbrock, N., Hamel, M., Hempel, B., Mitrovic, V.,
Schmidt, T., Wolf, G.K. 2001. Actions of
Standardized Extracts of Crataegus Berries on
Exercise Tolerance and Quality of Life in Patients
with Congestive Heart Failure [in German].
Arzneimittelforschung, 51(10):793–798.
Serçe, S., Şimşek, O., Toplu, C., Kamiloğlu, O., Çalişkan,
O., Gündüz, K. 2010. Relationships among Crataegus
Accessions Sampled from Hatay, Turkey, As
Assessed by Fruit Characteristics and RAPD. Genetic
Resources and Crop Evolution, 58: 933-42.
Scott, G.N., Elmer, G.W. 2002. Update on Natural
Product-Drug Interactions. American Journal of
Health System Pharmacy, 59 (4): 339–47.
Vierling, W., Brand, N., Gaedcke, F., Sensch, KH.,
Schneider, E., Scholz, M. 2003. Investigation of the
Pharmaceutical and Pharmacological Equivalence of
Different Hawthorn Extracts. Phytomedicine, 10: 8-
16.
Thank you for copying data from http://www.arastirmax.com
